Charles Schwab Investment Management Inc Ani Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 241,477 shares of ANIP stock, worth $14.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

241,477

Previous 196,483 22.9%

Holding current value

$14.2 Million

Previous $13.6 Million 13.22%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$58.53 - $68.82 $2.63 Million - $3.1 Million	44,994 Added 22.9%	241,477 $15.4 Million
Q1 2024 May 08, 2024	BUY	$54.2 - $69.69 $2.68 Million - $3.44 Million	49,431 Added 33.61%	196,483 $13.6 Million
Q4 2023 Feb 06, 2024	BUY	$48.72 - $65.43 $3,069 - $4,122	63 Added 0.04%	147,052 $8.11 Million
Q3 2023 Nov 08, 2023	BUY	$50.28 - $64.61 $5.48 Million - $7.04 Million	109,015 Added 287.08%	146,989 $8.53 Million
Q2 2023 Aug 09, 2023	BUY	$37.29 - $53.83 $109,446 - $157,991	2,935 Added 8.38%	37,974 $2.04 Million
Q1 2023 May 11, 2023	BUY	$37.61 - $45.72 $14,442 - $17,556	384 Added 1.11%	35,039 $1.39 Million
Q4 2022 Feb 13, 2023	BUY	$31.9 - $41.95 $43,734 - $57,513	1,371 Added 4.12%	34,655 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $18,255 - $23,262	612 Added 1.87%	33,284 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$23.09 - $33.46 $80,283 - $116,340	3,477 Added 11.91%	32,672 $970,000
Q1 2022 May 13, 2022	BUY	$26.91 - $47.15 $15,876 - $27,818	590 Added 2.06%	29,195 $821,000
Q4 2021 Feb 11, 2022	BUY	$32.97 - $56.85 $137,320 - $236,780	4,165 Added 17.04%	28,605 $1.32 Million
Q3 2021 Nov 16, 2021	SELL	$26.48 - $35.99 $1.19 Million - $1.61 Million	-44,853 Reduced 64.73%	24,440 $802,000
Q2 2021 Aug 16, 2021	BUY	$31.86 - $38.6 $317,038 - $384,108	9,951 Added 16.77%	69,293 $2.43 Million
Q1 2021 May 17, 2021	SELL	$28.4 - $36.14 $136,774 - $174,050	-4,816 Reduced 7.51%	59,342 $2.15 Million
Q4 2020 Feb 16, 2021	BUY	$23.69 - $31.47 $23,382 - $31,060	987 Added 1.56%	64,158 $1.86 Million
Q3 2020 Nov 13, 2020	BUY	$26.38 - $33.1 $7,386 - $9,268	280 Added 0.45%	63,171 $1.78 Million
Q2 2020 Aug 14, 2020	BUY	$29.93 - $50.1 $133,757 - $223,896	4,469 Added 7.65%	62,891 $2.03 Million
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $1.23 Million - $2.71 Million	-40,371 Reduced 40.86%	58,422 $2.38 Million
Q4 2019 Feb 07, 2020	BUY	$55.65 - $79.83 $60,102 - $86,216	1,080 Added 1.11%	98,793 $6.09 Million
Q3 2019 Nov 08, 2019	SELL	$64.7 - $85.39 $253,365 - $334,387	-3,916 Reduced 3.85%	97,713 $7.12 Million
Q2 2019 Aug 09, 2019	SELL	$67.77 - $82.2 $1.44 Million - $1.75 Million	-21,264 Reduced 17.3%	101,629 $8.35 Million
Q1 2019 May 14, 2019	BUY	$45.83 - $70.54 $114,345 - $175,997	2,495 Added 2.07%	122,893 $8.67 Million
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $600,793 - $823,628	14,593 Added 13.79%	120,398 $5.42 Million
Q3 2018 Nov 13, 2018	BUY	$52.95 - $71.34 $1.18 Million - $1.59 Million	22,229 Added 26.6%	105,805 $5.98 Million
Q2 2018 Aug 08, 2018	BUY	$56.38 - $68.08 $1.22 Million - $1.48 Million	21,700 Added 35.07%	83,576 $5.58 Million
Q1 2018 May 07, 2018	SELL	$56.98 - $72.41 $158,689 - $201,661	-2,785 Reduced 4.31%	61,876 $3.6 Million
Q4 2017 Jan 17, 2018	BUY	$53.3 - $74.56 $955,136 - $1.34 Million	17,920 Added 38.34%	64,661 $4.17 Million
Q3 2017 Nov 13, 2017	BUY	$43.46 - $52.49 $2.03 Million - $2.45 Million	46,741	46,741 $2.45 Million

Others Institutions Holding ANIP

# of Institutions

206

Shares Held

15M

Call Options Held

24K

Put Options Held

7.7K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Ani Pharmaceuticals Inc Transaction History